(Q44499434)

3 December 2017

Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products (English)

1 reference

3 December 2017

Narkunaraja Shanmugam

1

1 reference

3 December 2017

Young Sook Kim

2

1 reference

3 December 2017

Linda Lanting

3

1 reference

3 December 2017

Rama Natarajan

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

30 June 2003

1 reference

Journal of Biological Chemistry

3 December 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 December 2017

278

1 reference

3 December 2017

37

1 reference

3 December 2017

34834-34844

1 reference

Prostaglandin synthase 2.

3 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Autocrine/paracrine regulation of apoptosis in epithelial cells by prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Role of cyclooxygenase-2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Cytokines and nitric oxide in islet inflammation and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Structure of the human cyclo-oxygenase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Cyclooxygenase isozymes and their gene structures and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Induction of cyclooxygenase-2 by staurosporine through the activation of nuclear factor for IL-6 (NF-IL6) and activator protein 2 (AP2) in an osteoblast-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

High glucose enhances IL-1beta-induced cyclooxygenase-2 expression in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

The AGE-receptor in the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302828200

21 January 2018

Identifiers

DOI

10.1074/JBC.M302828200

1 reference

3 December 2017

1 reference